It might be time to look a bit off the beaten path, at names that can stand up to any AI-stock-led correction.

Five years on from being the first person in the world to receive intravenous CRISPR treatment, Westmeath woman describes the clinical trial she participated in as ‘life-changing’ ...

Five years ago this month, in November 2020, medical history was made at Richmond Pharmacology when a patient received the ...

Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery ...

Five years ago this month, in November 2020, medical history was made at London-based contract research organisation, Richmond Pharmacology, when a patient received the first CRISPR therapy delivered ...

Every year, the Future Perfect team curates the undersung activists, organizers, and thinkers who are making the world a ...

Only one in every six million people have the Rh null blood type. Now researchers are trying to grow it in the laboratory in the hope it could save lives.

Growing up in Tanzania, Prisca witnessed malaria as a daily reality with children missing school and families spending their limited savings on treatment. Witnessing how a preventable disease could ...

As reported in the Wall Street Journal, Armstrong has now officially entered the designer-baby business by funding heritable ...

Ben Lamm, founder of Colossal Biosciences, aims to revive extinct species like the woolly mammoth using advanced genetic technologies. , Business, Times Now ...

The Global Regenerative Medicine Market, valued at approximately USD 34.56 billion in 2023, is projected to witness an exponential surge, growing at a compound annual growth rate (CAGR) of 32.4% ...